FDA OKs anti-itch treatment Hydrocortisone-D from Apricus

08/23/2011 | San Diego Union-Tribune

Apricus Biosciences' Hydrocortisone-D, an anti-itch medicine, was approved by the FDA. The reformulated over-the-counter drug features Apricus' NexACT molecules, boosting drug absorption through the skin. Last week, the drugmaker gained regulatory approval for anti-fungal treatment Tolnaftate-D.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL